DOSE-RELATED PROLACTIN INHIBITORY EFFECT OF THE NEW LONG-ACTING DOPAMINE RECEPTOR AGONIST CABERGOLINE IN NORMAL CYCLING, PUERPERAL, AND HYPERPROLACTINEMIC WOMEN

被引：28

作者：

MELIS, GB ^{[1
]}

GAMBACCIANI, M ^{[1
]}

PAOLETTI, AM ^{[1
]}

BENEVENTI, F ^{[1
]}

MAIS, V ^{[1
]}

BAROLDI, P ^{[1
]}

FIORETTI, P ^{[1
]}

机构：

[1] FARMITALIA CARLO ERBA, DIV MED, MILAN, ITALY

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1987年 / 65卷 / 03期

关键词：

D O I：

10.1210/jcem-65-3-541

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：541 / 545

页数：5

共 18 条

[1]

BARBIERI RL, 1983, FERTIL STERIL, V39, P727

[2] CHRONIC TREATMENT OF PATHOLOGICAL HYPERPROLACTINEMIA AND ACROMEGALY WITH THE NEW ERGOT DERIVATIVE TERGURIDE [J].

DALLABONZANA, D ;

LIUZZI, A ;

OPPIZZI, G ;

COZZI, R ;

VERDE, G ;

CHIODINI, P ;

RAINER, E ;

DOROW, R ;

HOROWSKI, R .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) :1002-1007

[3]

DECECCO L, 1978, CLIN ENDOCRINOL, V9, P491

[4]

DELPOZO E, 1972, J CLIN ENDOCR METAB, V35, P768, DOI 10.1210/jcem-35-5-768

[5] TREATMENT OF HUMAN HYPERPROLACTINEMIA WITH A NEW DOPAMINE AGONIST - CU-32085 (MESULERGIN) [J].

DEWAILLY, D ;

THOMAS, P ;

BUVAT, J ;

WEMEAU, JL ;

FOURLINNIE, JC ;

LEMAITRE, G ;

MAZZUCA, M ;

FOSSATI, P .

ACTA ENDOCRINOLOGICA, 1985, 110 (04) :433-439

[6]

DISALLE E, 1984, 1ST S EUR NEUR ASS B, P122

[7]

DISALLE E, 1982, J ENDOCRINOL INVE S1, V5, P45

[8]

DISALLE E, 1984, J ENDOCRINOL INVE S1, V7, P32

[9]

DISALLE E, 1983, J ENDOCRINOL INVE S1, V6, P6

[10] LONG-LASTING PROLACTIN-LOWERING EFFECT OF CABERGOLINE, A NEW DOPAMINE AGONIST, IN HYPERPROLACTINEMIC PATIENTS [J].

FERRARI, C ;

BARBIERI, C ;

CALDARA, R ;

MUCCI, M ;

CODECASA, F ;

PARACCHI, A ;

ROMANO, C ;

BOGHEN, M ;

DUBINI, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) :941-945

← 1 2 →